| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Dec 8, 2025 | Celldex Therapeutics, Inc. | SVP & GENERAL COUNSEL | Sell | 22.5 | -4,166 | -11.92% | ✗ | $121.2K |
| Aug 13, 2025 | Aug 15, 2025 | Celldex Therapeutics, Inc. | SVP & GENERAL COUNSEL | Sell | 26.3 | -771 | -2.16% | ✗ | $19.1K |
| Jun 3, 2024 | Jun 5, 2024 | Celldex Therapeutics, Inc. | SVP & GENERAL COUNSEL | Sell | 20.0 | -8,006 | -23.60% | ✗ | $269K |
| Aug 11, 2021 | Aug 13, 2021 | Celldex Therapeutics, Inc. | SVP & General Counsel | Buy | 91.3 | +430 | 100.00% | ✗ | $19.9K |